US Patent Issued to JAPAN INSTITUTE FOR HEALTH SECURITY on March 24 for "Flavivirus cross neutralizing antibody and pharmaceutical composition" (Japanese Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,912, issued on March 24, was assigned to JAPAN INSTITUTE FOR HEALTH SECURITY (Tokyo).

"Flavivirus cross neutralizing antibody and pharmaceutical composition" was invented by Yoshimasa Takahashi (Tokyo), Arnone Nithichanon (Tokyo), Takayuki Matsumura (Tokyo), Ryosuke Suzuki (Tokyo), Chang-Kweng Lim (Tokyo) and Ganjana Lertmemongkolchai (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a flavivirus cross neutralizing antibody which has an excellent ability to control infection with suppressed ADE. This is a flavivirus cross neutralizing antibody that specifically binds to domains of E protein of flavivirus and thereby has an ability t...